Pelfizz Biotech Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 16-11-2024
- Paid Up Capital ₹ 2.50 M
as on 16-11-2024
- Company Age 20 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.52 Cr
as on 16-11-2024
- Satisfied Charges ₹ 1.55 Cr
as on 16-11-2024
- Revenue 1.49%
(FY 2023)
- Profit -4.40%
(FY 2023)
- Ebitda 1.27%
(FY 2023)
- Net Worth 8.99%
(FY 2023)
- Total Assets -6.27%
(FY 2023)
About Pelfizz Biotech
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.50 M.
The company currently has active open charges totaling ₹2.52 Cr. The company has closed loans amounting to ₹1.55 Cr, as per Ministry of Corporate Affairs (MCA) records.
Hemant Hajare, Neelam Singh, Kalapana Hajare, and One other member serve as directors at the Company.
- CIN/LLPIN
U24230MH2004PTC146186
- Company No.
146186
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 May 2004
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Pelfizz Biotech Private Limited offer?
Pelfizz Biotech Private Limited offers a wide range of products and services, including Bird Food, Poultry & Animal Food, Animal Feed Supplement.
Who are the key members and board of directors at Pelfizz Biotech?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hemant Hajare  | Director | 10-May-2004 | Current |
| Neelam Singh | Director | 07-Apr-2015 | Current |
| Kalapana Hajare | Director | 07-Apr-2015 | Current |
| Ashok Singh | Director | 10-May-2004 | Current |
Financial Performance of Pelfizz Biotech.
Pelfizz Biotech Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 1.49% increase. The company also saw a slight decrease in profitability, with a 4.4% decrease in profit. The company's net worth moved up by a moderate rise of 8.99%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pelfizz Biotech?
In 2023, Pelfizz Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Excellar Healthcare Private LimitedActive 17 years 9 monthsHemant Hajare and Ashok Singh are mutual person
- Excell Formulations Private LimitedActive 29 years 8 months
Hemant Hajare and Ashok Singh are mutual person
- Aahar Associates (India) Private LimitedActive 22 years 6 months
Hemant Hajare and Ashok Singh are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Janakalyan Sahakari Bank Limited Creation Date: 10 Mar 2011 | ₹8.00 M | Open |
Others Creation Date: 10 Mar 2011 | ₹1.72 Cr | Open |
Janakalyan Sahakari Bank Limited Creation Date: 20 Jan 2016 | ₹2.20 M | Satisfied |
How Many Employees Work at Pelfizz Biotech?
Pelfizz Biotech has a workforce of 16 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pelfizz Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pelfizz Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
